Fukuda, Naoki
Yoshida, Jumpei
Toda, Kazuhisa
Wang, Xiaofei
Oki, Ryosuke
Nakao, Takehiro
Urasaki, Tetsuya
Nakano, Kenji
Tomomatsu, Junichi
Mitani, Hiroki
Takahashi, Shunji
Miura, Yuji
Article History
Received: 25 December 2025
Accepted: 28 March 2026
First Online: 2 May 2026
Declarations
:
: The study was approved by the institutional review board of the Cancer Institute Hospital of the Japanese Foundation for Cancer Research (2024-GB-082) and adhered to the guidelines outlined in the Helsinki Declaration of 1964 and its subsequent revisions. The need for informed consent was waived in view of the retrospective observational nature of the research. However, in accordance with government policy in Japan, patients had the opportunity to decline participation via an opt-out route.
: N.F. has received personal fees from Eisai that are not relevant to the submitted work. The other authors report no conflicts of interest.